Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients
Go back to Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.77 -0.02 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.79 | 52 Week High | $16.89 | |||
| Open | $3.79 | 52 Week Low | $7.35 | |||
| Day High | $3.84 | P/E | N/A | |||
| Day Low | $3.73 | EPS | $-2.35 | |||
| Volume | 610,797 | |||||
